Page 9 of 18
The Journal of Organic Chemistry
1
2
3
4
5
6
solid (267 mg, 86% yield): mp: 77ꢀ78 °C; IR 3084, 3063, 3029, 2903, 1680, 1488, 1361,
1206, 748, 686 cmꢀ1; 1H NMR (500 MHz, CDCl3) δ 8.05 – 7.99 (m, 2H), 7.63 – 7.56 (m,
3H), 7.53 – 7.46 (m, 2H), 7.45 – 7.38 (m, 4H), 7.34 – 7.29 (m, 4H), 4.72 (dd, J = 7.9, 6.2
13
Hz, 1H), 3.72 (dd, J = 16.6, 7.9 Hz, 1H), 3.47 (dd, J = 16.6, 6.2 Hz, 1H); C NMR (125
7
MHz, CDCl3) δ 197.1, 141.3, 136.9, 133.2, 131.7, 128.8, 128.7, 128.3, 128.2, 127.9,
127.7, 127.2, 123.5, 90.8, 83.4, 47.3, 33.8; HRMS (ESI, TOF): Exact mass calcd for
C23H18ONa [M+Na]+, 333.1250; found, 333.1262.
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1-(4-Fluorophenyl)-3,5-diphenylpent-4-yn-1-one (5b) The title compound 19 was
prepared according to General Procedure A, using 4ꢀfluoroacetophenone (121 ꢀL, 138
mg, 1.00 mmol) and 1,3ꢀdiphenylpropꢀ2ꢀynꢀ1yl acetate (275 mg, 1.10 mmol). The
product was isolated as a white solid (271 mg, 83% yield): mp: 36ꢀ37 °C; IR 3089,
3036, 2933, 1666, 1592, 1506, 1488, 1322, 1258, 1234, 1159, 1026, 831, 756, 692 cmꢀ1;
1H NMR (500 MHz, CDCl3) δ 8.08 – 7.99 (m, 2H), 7.62 – 7.56 (m, 2H), 7.47 – 7.39 (m,
4H), 7.36 – 7.29 (m, 4H), 7.20 – 7.12 (m, 2H), 4.71 (dd, J = 7.9, 6.2 Hz, 1H), 3.69 (dd, J
= 16.6, 7.9 Hz, 1H), 3.43 (dd, J = 16.6, 6.2 Hz, 1H).13C NMR (125 MHz, CDCl3) δ
195.5, 165.9 (J = 255.0 Hz), 141.2, 133.4 (J = 3.0 Hz), 131.7, 130.9 (J = 9.3 Hz), 128.8,
128.2, 128.0, 127.6, 127.2, 123.4, 115.7 (J = 21.8 Hz), 90.7, 83.5, 47.2, 33.9.; HRMS
(ESI, TOF): Exact mass calcd for C23H17OFNa [M+Na]+, 351.1156; found, 351.1147.
1-(4-Bromophenyl)-3,5-diphenylpent-4-yn-1-one (5c) The title compound19 was
prepared according to General Procedure A, using 4ꢀbromoacetophenone (200 mg, 1.00
mmol) and 1,3ꢀdiphenylpropꢀ2ꢀynꢀ1yl acetate (275 mg, 1.10 mmol). The product was
isolated as an offꢀwhite solid (351 mg, 90% yield): mp: 95ꢀ98 °C; IR 3089, 3060, 3032,
2917, 2897, 2856, 1679, 1584, 1488, 1397, 1202, 1068, 996, 819, 756, 724, 693 cmꢀ1; 1H
NMR (500 MHz, CDCl3) δ 7.92 – 7.78 (m, 2H), 7.65 – 7.59 (m, 2H), 7.59 – 7.53 (m,
2H), 7.44 – 7.36 (m, 4H), 7.35 – 7.25 (m, 4H), 4.67 (dd, J = 7.9, 6.2 Hz, 1H), 3.66 (dd, J
= 16.6, 7.9 Hz, 1H), 3.41 (dd, J = 16.6, 6.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ
196.1, 141.1, 135.6, 132.0, 131.7, 129.8, 128.8, 128.5, 128.2, 128.0, 127.6, 127.2, 123.3,
90.6, 83.6, 47.2, 33.8; HRMS (ESI, TOF): Exact mass calcd for C23H17OBrNa [M+Na]+,
411.0355; found, 411.0345.
1-(4-Methoxyphenyl)-3,5-diphenylpent-4-yn-1-one (5d) The title compound19 was
prepared according to General Procedure B, using 4ꢀmethoxyacetophenone (200 mg, 1.00
mmol) and 1,3ꢀdiphenylpropꢀ2ꢀynꢀ1yl propionate (290 mg, 1.10 mmol). No additional
TMSOTf was added following the transfer via cannula. The product was isolated as a
pale yellow solid (252 mg, 74% yield): mp: 62ꢀ65 °C; IR 3080, 3055, 3023, 3009, 2963,
1
2935, 2896, 2840, 1673, 1597, 1486, 1257, 1168, 1024, 978, 827, 759, 693 cmꢀ1; H
NMR (500 MHz, CDCl3) δ 8.06 – 7.97 (m, 2H), 7.66 – 7.59 (m, 2H), 7.50 – 7.39 (m,
4H), 7.38 – 7.25 (m, 4H), 7.02 – 6.90 (m, 2H), 4.76 (dd, J = 7.8, 6.2 Hz, 1H), 3.85 (s,
3H), 3.69 (dd, J = 16.4, 7.8 Hz, 1H), 3.43 (dd, J = 16.4, 6.3 Hz, 1H); 13C NMR (126
MHz, CDCl3) δ 195.6, 163.7, 141.5, 131.7, 130.6, 130.1, 128.8, 128.3, 128.0, 127.7,
127.2, 123.6, 113.9, 91.2, 83.4, 55.5, 47.0, 34.0; HRMS (ESI, TOF): Exact mass calcd
for C24H20O2Na [M+Na]+, 363.1356; found, 363.1369.
ACS Paragon Plus Environment